LDS/Medical Tests/Helicobacter pylori and Antibiotic Resistance, Molecular

Helicobacter pylori and Antibiotic Resistance, Molecular

Helicobacter is a gram-negative curved organism that resides mostly in the human gastric mucosa. Helicobacter is found worldwide, but the exact mode of transmission is unknown. This bacterial pathogen is extremely robust, able to withstand stomach acid and survive on gastric mucosa where it multiplies, leading to tissue damage despite the mucosal immune system. Helicobacter infections are associated with chronic gastritis, gastric ulcers, gastric carcinoma, gastric lymphoma, and other diseases of the gastric mucosa.

Diagnosis can be made with both invasive and noninvasive procedures. The preferred method for diagnosis is a biopsy collected during endoscopy. The tissue can be analyzed for the presence of the actual organism using histochemical and immunohistochemical stains and light microscopy. One of the most common non-invasive procedures for diagnosing Helicobacter infections is the Breath test. The Breath test detects carbon dioxide that is hydrolyzed from the urease enzyme produced by Helicobacter. This test is very sensitive and can detect very low levels of bacteria. The other common noninvasive procedure for diagnosis of Helicobacter infection is the Helicobacter antibody test. Most infections can be diagnosed by the presence of the IgG antibody. Helicobacter IgM is useful for monitoring treatment due to its early appearance and disappearance when treatment is successful. Helicobacter IgA is rarely produced but is diagnostic of infection. Serological testing for Helicobacter is sensitive, non-invasive, convenient, and is performed on an outpatient basis.

The molecular method for detection of H. pylori either from stool or from the gastroscopic sample is the most sensitive and specific for confirmation of H. pylori infection. In addition, molecular method can test clarithromycin and fluoroquinolone resistance, which is most common used antibiotic to treat H. pylori infection.

  • Diagnosis of chronic active gastritis and peptic ulcer associated with Helicobacter infection
  • Diagnosis of infectious (Helicobacter) gastritis
  • Monitoring of treatment of Helicobacter infection

Positive in:

  • Helicobacter infection
  • Helicobacter induced gastritis with or without peptic ulcer disease
  • Some gastric cancers

Most infections can be diagnosed by the presence of the IgG antibody. Helicobacter IgM is useful for monitoring treatment due to its early appearance and disappearance when treatment is successful. Helicobacter IgA is rarely produced but is diagnostic of infection.

Not Detected (Negative)

Real-time Polymerase Chain Reaction (PCR), other Molecular methods.

Stool collected in a sterile container. 

Stability

  • Refrigerated - 72 hours
  • Frozen - 14 days

Tissue or gastric juice collected in a sterile container. 

Stability

  • Ambient - 1-3 days
Gastric biopsy, Pepsinogen I and II, Urea breath test, food allergy panel, Gastrin.
1-3 days
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • J Clin Microbiol 55:2400–2405. [PMID: 28515219]
  • J Clin Microbiol. 2020 Mar 25;58(4):e01787-19. [PMID: 31996442]
  • Clin Gastroenterol Hepatol. 2012 Jan 7. [PMID: 22230167]
  • J Pediatr. 2005;146:S21. [PMID: 15758899]
  • Gastroenterol Clin North Am. 2006;35:229. [PMID: 16880064]
  • Aust Fam Physician. 2008 Aug;37(8):608-12. [PMID: 18704207]
  • Helicobacter. 2009 Sep;14 Suppl 1:46-51. [PMID: 19712168]
  • Jacobs DS, DeMott WR. Laboratory test handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).
  • Betty Forbes DF. Bailey & Scott's Diagnostic Microbiology 12th. St. Louis: Mosby Elsevier (2007).